1. Home
  2. Analysis
  3. Ilaris
  4. Viral-gastroenteritis

Ilaris and Viral gastroenteritis - a phase IV clinical study of FDA data

Summary:

Viral gastroenteritis is reported as a side effect among people who take Ilaris (canakinumab), especially for people who are male, 10-19 old, have been taking the drug for 6 - 12 months also take Amoxicillin, and have Bronchiolitis.

The phase IV clinical study analyzes which people have Viral gastroenteritis when taking Ilaris. It is created by eHealthMe based on reports of 13,051 people who have side effects when taking Ilaris from the FDA, and is updated regularly.

What is Ilaris?

Ilaris has active ingredients of canakinumab. eHealthMe is studying from 13,059 Ilaris users. Check the latest studies of Ilaris.

What is Viral gastroenteritis?

Viral gastroenteritis is found to be associated with 89 drugs and 336 conditions by eHealthMe. Check the latest studies of Viral gastroenteritis.

On Jan, 06, 2026

13,051 people reported to have side effects when taking Ilaris.
Among them, 19 people (0.15%) have Viral gastroenteritis.

Could Ilaris cause Viral gastroenteritis?

Among these 19 people:

How long have people been on Ilaris when they have Viral gastroenteritis? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 60 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 40 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Viral gastroenteritis when taking Ilaris? *

  • female: 47.37 %
  • male: 52.63 %

What is the age of people who have Viral gastroenteritis when taking Ilaris? *

  • 0-1: 5.26 %
  • 2-9: 42.11 %
  • 10-19: 52.63 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Ilaris? *

  1. Lamotrigine: 3 people, 15.79%
  2. Amoxicillin: 3 people, 15.79%

What are other side effects people have besides Viral gastroenteritis? *

  1. Fever: 18 people, 94.74%
  2. Weight Increased: 15 people, 78.95%
  3. Tonsillitis (inflammation of tonsil): 14 people, 73.68%
  4. Rashes (redness): 13 people, 68.42%
  5. Tonsillitis Streptococcal (bacterial infection of tonsil): 10 people, 52.63%
  6. Inflammation: 10 people, 52.63%
  7. Viral Infection: 9 people, 47.37%
  8. Febrile Convulsion (a convulsion associated with a significant rise in body temperature): 8 people, 42.11%
  9. Drug Ineffective: 8 people, 42.11%
  10. Haemophilus Test Positive: 8 people, 42.11%

What are the existing conditions these people have? *

  1. Familial Mediterranean Fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash): 1 person, 5.26%
  2. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ilaris and have Viral gastroenteritis?

- Check whether Viral gastroenteritis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ilaris:

Viral gastroenteritis treatments and more:

How severe was Viral gastroenteritis and when was it recovered:

Expand to all the drugs that have ingredients of canakinumab:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ilaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Viral gastroenteritis:

Browse all the conditions that are associated with Viral gastroenteritis:

How the study uses the data?

The study uses data from the FDA. It is based on canakinumab (the active ingredients of Ilaris) and Ilaris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.